TMCnet News
Research and Markets: Introducing the 1st Edition of 'Single Cell Genomics (SCG) Report 2013'DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/md2x8x/single_cell) has announced the addition of the "Single Cell Genomics (SCG) Report 2013: Market Size, Segmentation, Growth, Competition and Trends" report to their offering. Single cell genomics (SCG) is a fast growing, emerging approach in which genomic technologies (i.e., that assess nucleic acids such as DNA or RNA) are applied at the level of single cells, rather than at the level of an entire cell population. The first edition of this report reviews the market size, segmentation, growth and trends of the SCG market. The author assesses the SCG market across 7 segments and 32 sub-segments: - Customer (academia, biopharma, applied markets, clinical) - Workflow step (cell isolation, sample preparation, genomic analysis) - Analytical technology (PCR (News - Alert), qPCR, microarry, next-generation-sequencing, other) - Field-of-study (oncology, basic cell biology, stem cell biology, microbiology, neurology, immunology, other) - Application (genomic variation, subpopulation characterization, circulating tumor cells, cell differentiation / reprogramming, method, other) - Product type (instruments, reagents) - Geography (U.S., Europe, Japan, Asia-Pacific, ROW) For each of these segments, the author provides an estimated market size and growth from 2009 to 2018, as well as key growth drivers and moderators. In addition, we review key factors driving future growth including 1) accelerating interest among scientists given a number of applications that SCG can enable, 2) launch of new platforms that streamline the historically laborious and low throughput workflow, 3) development of new protocols and reagents optimized to improve the amplification of DNA/RNA from single cells for downstream analysis and 5) adoption of SCG by new customers segments, most notably clinical laboratories. On the other hand, the author discusses several key factors moderating growth including 1) remaining workflow challenges, including isolating cells from tissue and recovering DNA / RNA at a high yield, amplifying DNA / RNA with limited bias and downstream computational analysis, 2) continued funding pressures for academic customers (currently representing the majority of the market) particularly in the U.S. and Europe. Special analysis conducted in this report includes the analysis and categorization of -300 SCG publications published since 2007. For more information visit http://www.researchandmarkets.com/research/md2x8x/single_cell About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. |
